Interference of gadolinium on the measurement of selenium in human serum by inductively coupled plasma-quadrupole mass spectrometry

Annals of Clinical Biochemistry

Volumn 48, Issue 2, 2011, Pages 176-177

  Walter, Alan ^a   Nelms, Simon ^b   Harrington, Chris F ^a   Taylor, Andrew ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b Thermo Fisher Scientific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; SELENIUM;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CASE REPORT; CHRONIC FATIGUE SYNDROME; HUMAN; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY;

ARTIFACTS; BLOOD CHEMICAL ANALYSIS; FEMALE; GADOLINIUM; HUMANS; MASS SPECTROMETRY; SELENIUM;

EID: 79952999279     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2010.010030     Document Type: Article

References (7)

1. Taylor A. Detection and monitoring for disorders of essential trace elements. Ann Clin Biochem 1996;33:486-510 (Pubitemid 26397712)
2. Clark L, Combs G, Turnbull B, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996;276:1957-63 (Pubitemid 26427723)
3. Verlinen M, van Sprundel M, Van der Auwere JC, et al. The selenium status of Belgian population groups 1. Healthy adults. Biol Trace Elem Res 1983;5:91-102
4. Spinazzi A, Lorusso V, Pirovano G, Kirchin M. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine. Acta Radiol 1999;6:282-91
5. Swan SK, Lambrecht LJ, Townsend R, et al. Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment. Invest Radiol 1999;34:443-8 (Pubitemid 29302836)
6. Davies BE, Kirchin MA, Bensel K, et al. Pharmacokinetics and safety of gadobenate dimeglumine (Multihance) in subjects with impaired liver function. Invest Radiol 2002;37:299-308 (Pubitemid 34461676)
7. Strunk HM, Schild H. Actual clinical use of gadolinium-chelates for non-MRI applications. Eur Radiol 2004;14:1055-62 (Pubitemid 38787250)